Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

13 Aug 2021

Abstract excerpt

BACKGROUND: A RNA methylation regulator small nuclear ribonucleoprotein polypeptide C (SNRPC), which encodes one of the specific protein components of the U1 small nuclear ribonucleoprotein (snRNP) particle, has been proven to be related to the prognosis of patients with HCC. However, the effect of SNRPC on the tumor microenvironment and immunotherapy in HCC remains unclear. CASE PRESENTATION: The HCC RNA-seq...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34389000
DOI: 10.1186/s12957-021-02354-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinomaPMID 34389000Read ↗

The m6A Methylation Gene SNRPC can be used as a Biomarker for the Prognosis and Immunotherapy of Hepatocellular CarcinomaSemantic proximity Read ↗

m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Significance of m 6A Methyltransferase‑Related lncRNAs in the Prognosis and Immunotherapy of Hepatocellular CarcinomaSemantic proximity Read ↗

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinomaSemantic proximity Read ↗

Correlation Between the RNA Methylation Genes and Immune Infiltration and Prognosis of Patients with Hepatocellular Carcinoma: A Pan-Cancer AnalysisSemantic proximity Read ↗

RNA m6A methylation regulator-mediated modification patterns and tumor microenvironment characterization in hepatocellular carcinomaSemantic proximity Read ↗

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinomaSemantic proximity Read ↗

M6a Regulator-Associated Methylation Modification Patterns Shape Tumor Microenvironment Characteristics in Hepatocellular CarcinomaSemantic proximity Read ↗

Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.Semantic proximity Read ↗

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

The Significance of Prognostic m6A RNA Methylation Regulators in Tumor Immune Environment and Immune Therapy of Hepatocellular CarcinomaSemantic proximity Read ↗

Deciphering m6A signatures in hepatocellular carcinoma: Single‐cell insights, immune landscape, and the protective role of IGFBP3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.